Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No
iwMyeloma 2020 Session II

Novel Targets

Presentations
Update on ubiquitin ligases, Celmods and new IMiDs
Ken Anderson
26 September, 2020
Targeting MCL1 and BCL2 inhibition
Larry Boise
26 September, 2020
Therapeutic trials in MGUS and SMM
Maria V Mateos
26 September, 2020
PIKfyve- a novel target in Myeloma
Keith Stewart
26 September, 2020
Previous session View all sessions Next session

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals